Bauer M, Wetzker R
Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
Integrated Research and Treatment Center Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Med Klin Intensivmed Notfmed. 2020 May;115(Suppl 1):4-9. doi: 10.1007/s00063-020-00673-4. Epub 2020 Mar 31.
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. This definition, updated in 2016, shifted the conceptual focus from exclusive attention to the systemic inflammatory response toward the multifactorial tissue damage that occurs during the progression of infection to sepsis and shock. Whereas targeting the inflammatory host response to infection did not translate into improved clinical management of sepsis, recent findings might shed new light on the maladaptive host-pathogen interaction in sepsis and pave the way for "theranostic" interventions. In addition to the well-known resistance responses of the immune system that result in pathogen clearance, "disease tolerance" has recently been acknowledged as a coping mechanism of presumably equal importance. We propose that both defense mechanisms, "resistance" and "disease tolerance", can get out of control in sepsis. Whereas excessive activation of resistance pathways propagates tissue damage via immunopathology, an inappropriate "tolerance" might entail immunoparalysis accompanied by fulminant, recurrent or persisting infection. The review introduces key signaling processes involved in infection-induced "resistance" and "tolerance". We propose that elaboration of these signaling pathways allows novel insights into sepsis-associated tissue damage and repair processes. Moreover theranostic opportunities for the specific treatment of sepsis-related hyperinflammation or immunoparalysis will be introduced. Agents specifically affecting either hyperinflammation or immunoparalysis in the course of sepsis might add to the therapeutic toolbox of personalized care in the field of organ dysfunction caused by infection. (This article is freely available.).
脓毒症被定义为由宿主对感染的失调反应引起的危及生命的器官功能障碍。这一定义于2016年更新,将概念重点从单纯关注全身炎症反应转向了感染进展为脓毒症和休克过程中发生的多因素组织损伤。虽然针对感染的炎症宿主反应并未转化为脓毒症临床管理的改善,但最近的研究结果可能为脓毒症中适应不良的宿主-病原体相互作用带来新的启示,并为“治疗诊断”干预铺平道路。除了免疫系统导致病原体清除的众所周知的抵抗反应外,“疾病耐受”最近也被认为是一种同样重要的应对机制。我们认为,在脓毒症中,“抵抗”和“疾病耐受”这两种防御机制都可能失控。抵抗途径的过度激活通过免疫病理学传播组织损伤,而不适当的“耐受”可能导致免疫麻痹,并伴有暴发性、复发性或持续性感染。本文综述了感染诱导的“抵抗”和“耐受”所涉及的关键信号传导过程。我们认为,对这些信号通路的阐述有助于深入了解脓毒症相关的组织损伤和修复过程。此外,还将介绍针对脓毒症相关过度炎症或免疫麻痹的特异性治疗的治疗诊断机会。在脓毒症过程中特异性影响过度炎症或免疫麻痹的药物可能会增加感染引起的器官功能障碍领域个性化护理的治疗手段。(本文可免费获取。)